151 related articles for article (PubMed ID: 15705639)
1. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
Decousser JW; Methlouthi I; Pina P; Allouch P;
J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639
[No Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.
Feldman C; Brink AJ; von Gottberg A; Wolter N; de Gouveia L; Perovic O; Klugman KP
Int J Antimicrob Agents; 2010 Jul; 36(1):95-7. PubMed ID: 20378315
[No Abstract] [Full Text] [Related]
3. Activity of the new quinolone WCK 771 against pneumococci.
Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF
Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298
[TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
Fogarty C; Goldschmidt R; Bush K
Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
8. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
9. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
10. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
Jacobs MR
Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
[No Abstract] [Full Text] [Related]
11. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
File TM; Mandell LA
Clin Infect Dis; 2003 Feb; 36(4):396-8. PubMed ID: 12567295
[No Abstract] [Full Text] [Related]
12. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
13. [Utility of blood cultures on antibiotic therapy in adult bacteremic pneumococcal pneumonia].
Mathurin L S; Agüero L A; Jaimet A C; Schälibaum G E; Demergasso S M; Acuña S V
Rev Chilena Infectol; 2009 Feb; 26(1):9-17. PubMed ID: 19350153
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
15. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
16. How artificial is the antibiotic resistance definition?
Diene SM; Abat C; Rolain JM; Raoult D
Lancet Infect Dis; 2017 Jul; 17(7):690. PubMed ID: 28653629
[No Abstract] [Full Text] [Related]
17. Primary lung abscess caused by multidrug-nonsusceptible Streptococcus pneumoniae in a child.
Holston AM; Miller JR
Pediatr Infect Dis J; 2006 Feb; 25(2):182-3. PubMed ID: 16462303
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.
Decousser JW; Pina P; Picot F; Allouch PY
Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):561-5. PubMed ID: 12942341
[TBL] [Abstract][Full Text] [Related]
19. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
Ross JJ; Worthington MG; Gorbach SL
N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
[No Abstract] [Full Text] [Related]
20. Rare presentation of Streptococcus pneumoniae pneumonia with bacteremia and multiple subcutaneous abscesses.
Shahin GS; Lerner SA
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):611-2. PubMed ID: 12226693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
